Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We and others have showed the association of MCL1 and Bcl-xL expression with tumor progression and survival in solid tumors including CRC [30, 48–52].”
From MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma (2022) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-Analysis Group In Cancer (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.252 · Cited by 441
Research works printed but not linked: 54
- Advanced colorectal cancer meta-analysis project, 1992, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate, J Clin Oncol, 10, 896, 10.1200/JCO.1992.10.6.896 · DOI · Paper page
- Peters, 1994, Thymidylate synthase inhibition after administration of 5-fiuorouracil with or without leucovorin; implications for treatment with 5-fluorouracil, J Clin Oncol, 12, 2035, 10.1200/JCO.1994.12.10.2035 · DOI · Paper page
- Mini, 1990, Enhancement of the anti-tumor effects of 5-fluorouracil by folinic acid, Pharmacol Ther, 47, 1, 10.1016/0163-7258(90)90042-Z · DOI
- Leichman, 1997, Quantification of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin, J Clin Oncol, 15, 3223, 10.1200/JCO.1997.15.10.3223 · DOI · Paper page
- Lenz, 1998, P53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival, Clin Cancer Res, 4, 1243
- Davies, 1999, Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine, Clin Cancer Res, 5, 325
- Aschele, 1999, Immunohistochemical quantification of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy, J Clin Oncol, 17, 1760, 10.1200/JCO.1999.17.6.1760 · DOI · Paper page
- Casinu, 1996, Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil, Clin Cancer Res, 5, 1996
- Kastan, 1995, P53, cell cycle control and apoptosis Implications for cancer, Cancer Metast Rev, 14, 3, 10.1007/BF00690207 · DOI · Paper page
- El-Deiry, 1993, WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817, 10.1016/0092-8674(93)90500-P · DOI · Paper page
- Weinberg, 1995, The retinoblastoma protein and cell cycle control, Cell, 81, 323, 10.1016/0092-8674(95)90385-2 · DOI · Paper page
- Degregori, 1995, Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and GI/S-regulatory genes, Mol Cell Biol, 15, 4215, 10.1128/MCB.15.8.4215 · DOI · Paper page
- Miyashita, 1994, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, 9, 1799
- Korsmeyer, 1995, Regulators of cell death, Trends Genet, 11, 101, 10.1016/S0168-9525(00)89010-1 · DOI · Paper page
- Allen, 1998, Mechanisms controlling cellular suicide: Role of bcl-2 and caspases, Cell Mol Life Sci, 54, 427, 10.1007/s000180050171 · DOI · Paper page
- Nagata, 1997, Apoptosis by death factor, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7 · DOI · Paper page
- Lazebnik, 1994, Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE, Nature, 371, 346, 10.1038/371346a0 · DOI · Paper page
- Caulin, 1997, Caspase cleavage of Keratin 18 and reorganisation of intermediate filaments during epithelial cell apoptosis, J cell Biol, 138, 1379, 10.1083/jcb.138.6.1379 · DOI · Paper page
- Nagata, 1995, The Fas death factor, Science, 267, 1449, 10.1126/science.7533326 · DOI · Paper page
- Van Riel JMGH, van Groeningen CJ, Albers SHM et al. Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: Single centre experience in 145 patients Ann Oncol (in press).
- Van Triest, 2000, Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody, J Histochem Cytochem, 48, 755, 10.1177/002215540004800604 · doi:10.1177/002215540004800604
- Anderson, 1996, Retinoblastoma protein in human breast carcinoma. Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues, J Pathol, 180, 65, 10.1002/(SICI)1096-9896(199609)180:1<65::AID-PATH607>3.0.CO;2-C · DOI
- Leers, 1999, Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis, J Pathol, 187, 567, 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J · DOI · Paper page
- Lamarra, 1988, Structural and functional analysis of poly(ADP ribose) polymerase: An immunological study, Biochim Biophys Acta, 950, 147, 10.1016/0167-4781(88)90007-3 · DOI
- Cifone, 1994, Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase, J Exp Med, 180, 1547, 10.1084/jem.180.4.1547 · DOI · Paper page
- Sinicrope, 1998, Loss of p21WAF1/Cipl protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers, Clin Cancer Res, 4, 1251
- Fernandes-Alnemri, 1994, CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme, J Biol Chem, 269, 30761, 10.1016/S0021-9258(18)47344-9 · DOI · Paper page
- Mann, 1999, FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas, Br J Cancer, 79, 1262, 10.1038/sj.bjc.6690202 · DOI
- Van Triest, 2000, Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet derived endothelial cell growth factor, and proliferation markers in colorectal cancer, Clin Cancer Res, 6, 1063
- Kanavaros, 1999, Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas, Med Oncol, 16, 23, 10.1007/BF02787355 · DOI
- Mosnier, 1996, An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum, Arch Pathol Lab Med, 120, 654
- Krajewska, 1996, Elevated expression of bcl-x and reduced bak in primary colorectal adenocarcinomas, Cancer Res, 56, 2422
- Krajewska, 1994, Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2, Am J Pathol, 145, 1323
- Krajewska, 1995, Immunohistochemical analysis of mcl-l protein in human tissues, Am J Pathol, 146, 1309
- Backus HHJ, Dukers DF, van Groeningen CJ et al. 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients. Ann Oncol (in press).
- Bobrow, 1989, Catalyzed reporter deposition, a novel method of signal amplification. I Application for immunoassays, J Immunol Methods, 125, 279, 10.1016/0022-1759(89)90104-X · DOI · Paper page
- Poller, 1997, P53 and Rbl protein expression Are they prognostically useful in colorectal cancer?, Br J Cancer, 75, 87, 10.1038/bjc.1997.14 · DOI
- Sinicrope, 1995, Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis, Cancer Res, 55, 237
- Sinicrope, 1999, Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas, Clin Cancer Res, 5, 1793
- Lenz, 1998, P53 and thymidylate synthase expression in untreated stage II colon cancer: Associations with recurrence, survival, and site. Clin Cancer Res, 4, 1227
- Yoong, 1999, Fas/Fas ligand interaction in human colorectal hepatic metastases, Am J Pathol, 154, 693, 10.1016/S0002-9440(10)65316-3 · DOI
- Ogura, 1999, Prognostic significance of bcl-2, bcl-xL/S, bax and bak expressions in colorectal carcinomas, Oncol Rep, 6, 365
- Fleege, 1990, Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry, Lab Invest, 63, 270
- Dukers, 2000, Quantitative immuno-histochemical analysis of cytokine profiles in Epstein–Barr virus-positive and -negative cases of Hodgkin’s disease, J Pathol, 190, 143, 10.1002/(SICI)1096-9896(200002)190:2<143::AID-PATH519>3.0.CO;2-5 · doi:10.1002/(sici)1096-9896(200002)190:2<143::aid-path519>3.0.co;2-5
- Paradiso, 2000, Thymidylate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients, Br J Cancer, 82, 560, 10.1054/bjoc.1999.0964 · DOI
- Ali, 1993, Rbl protein in normal and malignant human colorectal tissue and colon cancer cell lines, FASEB J, 7, 931, 10.1096/fasebj.7.10.8344490 · DOI
- Van Triest, 2000, Downstream molecular determinants of response to 5-fluorouracil and antifolate synthase inhibitors, Ann Oncol, 11, 385, 10.1023/A:1008351221345 · DOI · Paper page
- Dix, 1994, Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas, Br J Cancer, 70, 585, 10.1038/bjc.1994.355 · DOI
- Belluco, 1996, P53 nuclear protein overexpression in colorectal cancer: A dominant predictor of survival in patients with advanced hepatic metastases, J Clin Oncol, 14, 2696, 10.1200/JCO.1996.14.10.2696 · DOI
- Paradiso, 1996, P53 and PCNA expression in advanced colorectal cancer: Response to chemotherapy and long-term prognosis, Int J Cancer, 69, 437, 10.1002/(SICI)1097-0215(19961220)69:6<437::AID-IJC2>3.0.CO;2-5 · doi:10.1002/(sici)1097-0215(19961220)69:6<437::aid-ijc2>3.0.co;2-5
- Brett, 1996, P53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer, Eur J Sur Oncol, 22, 182, 10.1016/S0748-7983(96)90827-6 · DOI
- Nita, 1998, 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of bcl-2 family proteins, Br J Cancer, 78, 986, 10.1038/bjc.1998.617 · DOI · Paper page
- Peters, 2000, Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed, Eur J Cancer, 36, 916, 10.1016/S0959-8049(00)00026-5 · DOI
- Schneider, 1997, Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas, Br J Cancer, 75, 427, 10.1038/bjc.1997.70 · DOI
Cited by
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
Peters, G. J., Backus, H. H. J., Freemantle, S., van Triest, B., Codacci-Pisanelli, G., van der Wilt, C. L., Smid, K., Lunec, J., Calvert, A. H., Marsh, S., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00082-0 · Cited by 420
Self-citationKemeny, N. E., Niedzwiecki, D., Hollis, D. R., Lenz, H.-J., Warren, R. S., Naughton, M. J., Weeks, J. C., Sigurdson, E. R., Herndon, J. E., Zhang, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8166 · Cited by 417
Placzek, W. J., Wei, J., Kitada, S., Zhai, D., Reed, J. C., & Pellecchia, M. (2010) · Cell Death & Disease · doi:10.1038/cddis.2010.18 · Cited by 294
Noordhuis, P., Holwerda, U., Van der Wilt, C. L., Van Groeningen, C. J., Smid, K., Meijer, S., Pinedo, H. M., & Peters, G. J. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh264 · Cited by 264
Self-citationMCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
Fu, D., Pfannenstiel, L., Demelash, A., Phoon, Y. P., Mayell, C., Cabrera, C., Liu, C., Zhao, J., Dermawan, J., Patil, D., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-021-04334-y · Cited by 29
Metadata
- Authors
- Backus, H. H. J., van Riel, J. M. G. H., van Groeningen, C. J., Vos, W., Dukers, D. F., Bloemena, E., Wouters, D., Pinedo, H. M., & Peters, G. J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 12
- Issue
- 6
- Pages
- 779-785
- ISSN
- 0923-7534
- Cited by
- 47
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6794 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer. https://app.cochat.ai/papers/10.1023/a:1011112227044
- The paper
- Backus, H. H. J., van Riel, J. M. G. H., van Groeningen, C. J., Vos, W., Dukers, D. F., Bloemena, E., Wouters, D., Pinedo, H. M., & Peters, G. J. (2001). Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer. Annals of Oncology. https://doi.org/10.1023/a%3A1011112227044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.